Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 23 | 2023 | 77 | 6.110 |
Why?
|
| Osteoporotic Fractures | 8 | 2022 | 12 | 3.640 |
Why?
|
| Absorptiometry, Photon | 20 | 2022 | 84 | 2.890 |
Why?
|
| Bone Density | 22 | 2022 | 144 | 2.050 |
Why?
|
| Bone Density Conservation Agents | 4 | 2022 | 14 | 1.920 |
Why?
|
| Risk Assessment | 11 | 2022 | 624 | 1.440 |
Why?
|
| Femur Neck | 4 | 2017 | 21 | 1.150 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2022 | 5 | 1.130 |
Why?
|
| Fractures, Bone | 7 | 2011 | 73 | 0.840 |
Why?
|
| Societies, Medical | 9 | 2013 | 121 | 0.790 |
Why?
|
| Diphosphonates | 3 | 2023 | 19 | 0.710 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 144 | 0.660 |
Why?
|
| Risk Factors | 12 | 2023 | 2302 | 0.620 |
Why?
|
| Practice Guidelines as Topic | 5 | 2013 | 261 | 0.570 |
Why?
|
| Calcaneus | 1 | 2017 | 4 | 0.560 |
Why?
|
| Secondary Prevention | 4 | 2021 | 51 | 0.560 |
Why?
|
| Congresses as Topic | 2 | 2013 | 32 | 0.530 |
Why?
|
| Humans | 35 | 2023 | 27074 | 0.520 |
Why?
|
| Ultrasonography | 2 | 2017 | 227 | 0.510 |
Why?
|
| Hip Fractures | 4 | 2023 | 26 | 0.460 |
Why?
|
| Patient Compliance | 1 | 2014 | 150 | 0.430 |
Why?
|
| Algorithms | 5 | 2021 | 350 | 0.350 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 161 | 0.350 |
Why?
|
| Jaw Diseases | 1 | 2009 | 1 | 0.320 |
Why?
|
| Osteonecrosis | 1 | 2009 | 16 | 0.320 |
Why?
|
| Collagen Type I | 1 | 2009 | 19 | 0.310 |
Why?
|
| Peptides | 1 | 2009 | 102 | 0.300 |
Why?
|
| Densitometry | 1 | 2007 | 9 | 0.290 |
Why?
|
| Spinal Fractures | 3 | 2017 | 43 | 0.270 |
Why?
|
| Electronic Health Records | 2 | 2018 | 73 | 0.270 |
Why?
|
| Spine | 1 | 2007 | 108 | 0.260 |
Why?
|
| Accidental Falls | 2 | 2021 | 110 | 0.250 |
Why?
|
| Lumbar Vertebrae | 2 | 2007 | 383 | 0.250 |
Why?
|
| Radiation Monitoring | 1 | 2005 | 1 | 0.240 |
Why?
|
| Safety Management | 1 | 2005 | 13 | 0.240 |
Why?
|
| Primary Prevention | 2 | 2017 | 29 | 0.230 |
Why?
|
| Female | 10 | 2022 | 15213 | 0.220 |
Why?
|
| Retrospective Studies | 4 | 2023 | 3538 | 0.210 |
Why?
|
| Periprosthetic Fractures | 1 | 2023 | 26 | 0.210 |
Why?
|
| Middle Aged | 6 | 2022 | 8923 | 0.210 |
Why?
|
| Denosumab | 1 | 2022 | 1 | 0.200 |
Why?
|
| Teriparatide | 1 | 2022 | 1 | 0.200 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2022 | 1 | 0.200 |
Why?
|
| Alendronate | 1 | 2022 | 7 | 0.200 |
Why?
|
| Adult | 8 | 2022 | 7831 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 57 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 1990 | 310 | 0.170 |
Why?
|
| Child | 6 | 2009 | 1295 | 0.170 |
Why?
|
| Aged | 5 | 2022 | 8997 | 0.160 |
Why?
|
| Cytochrome c Group | 3 | 1990 | 4 | 0.160 |
Why?
|
| Cytochromes c | 3 | 1990 | 11 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 1990 | 14 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1990 | 23 | 0.160 |
Why?
|
| Bone and Bones | 2 | 2009 | 116 | 0.140 |
Why?
|
| Finger Phalanges | 1 | 2017 | 2 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 17 | 0.140 |
Why?
|
| Cancellous Bone | 1 | 2017 | 5 | 0.140 |
Why?
|
| Protein Biosynthesis | 3 | 1988 | 16 | 0.140 |
Why?
|
| Radius | 1 | 2017 | 33 | 0.140 |
Why?
|
| Male | 8 | 2018 | 14772 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 683 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2018 | 119 | 0.130 |
Why?
|
| Canada | 2 | 2014 | 47 | 0.130 |
Why?
|
| United States | 1 | 2022 | 2035 | 0.130 |
Why?
|
| Hospitalization | 1 | 2018 | 300 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2023 | 810 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 255 | 0.120 |
Why?
|
| Tibia | 1 | 2017 | 245 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 891 | 0.120 |
Why?
|
| Chicago | 1 | 2018 | 949 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 1991 | 38 | 0.110 |
Why?
|
| Forensic Anthropology | 1 | 2014 | 1 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 22 | 0.110 |
Why?
|
| ROC Curve | 1 | 2014 | 141 | 0.110 |
Why?
|
| Adolescent | 4 | 2022 | 2172 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2014 | 260 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2010 | 17 | 0.100 |
Why?
|
| Trans-Activators | 2 | 1991 | 25 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 347 | 0.100 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 1991 | 1 | 0.090 |
Why?
|
| Chimera | 1 | 1991 | 3 | 0.090 |
Why?
|
| Morbidity | 1 | 2011 | 54 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 18 | 0.090 |
Why?
|
| Recurrence | 1 | 2012 | 310 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2010 | 72 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2010 | 83 | 0.080 |
Why?
|
| World Health Organization | 1 | 2008 | 9 | 0.080 |
Why?
|
| Mutation | 3 | 1990 | 348 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2014 | 1890 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 145 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 77 | 0.070 |
Why?
|
| Observer Variation | 1 | 2007 | 96 | 0.070 |
Why?
|
| Pediatrics | 1 | 2008 | 39 | 0.070 |
Why?
|
| Software | 1 | 2007 | 61 | 0.070 |
Why?
|
| Reference Values | 1 | 2007 | 186 | 0.070 |
Why?
|
| Internet | 1 | 2007 | 91 | 0.070 |
Why?
|
| Biomarkers | 1 | 2009 | 562 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 759 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2006 | 90 | 0.060 |
Why?
|
| Age Factors | 3 | 2010 | 766 | 0.050 |
Why?
|
| Base Sequence | 5 | 1990 | 109 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 1990 | 107 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1990 | 156 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1990 | 169 | 0.040 |
Why?
|
| Reoperation | 1 | 2023 | 925 | 0.040 |
Why?
|
| HeLa Cells | 4 | 1991 | 42 | 0.040 |
Why?
|
| Alleles | 3 | 1990 | 216 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1990 | 195 | 0.030 |
Why?
|
| Kinetics | 2 | 1991 | 188 | 0.030 |
Why?
|
| Young Adult | 2 | 2009 | 1994 | 0.020 |
Why?
|
| Genes, Fungal | 2 | 1990 | 2 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 2 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1991 | 19 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 27 | 0.020 |
Why?
|
| Mammals | 1 | 1991 | 25 | 0.020 |
Why?
|
| Temperature | 1 | 1991 | 63 | 0.020 |
Why?
|
| DNA | 1 | 1991 | 106 | 0.020 |
Why?
|
| Transfection | 1 | 1991 | 121 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 127 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2010 | 2 | 0.020 |
Why?
|
| Asia | 1 | 2010 | 10 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 57 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1990 | 4 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1990 | 31 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1990 | 5 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1990 | 7 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1990 | 13 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 39 | 0.020 |
Why?
|
| Apoenzymes | 1 | 1990 | 1 | 0.020 |
Why?
|
| Apoproteins | 1 | 1990 | 1 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1990 | 50 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 2009 | 8 | 0.020 |
Why?
|
| New Mexico | 1 | 2009 | 3 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1988 | 8 | 0.020 |
Why?
|
| Genes | 1 | 1988 | 7 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 16 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1990 | 276 | 0.020 |
Why?
|
| Bone Development | 1 | 2008 | 32 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1987 | 4 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1987 | 21 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1987 | 16 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 474 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1987 | 37 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1987 | 83 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 464 | 0.020 |
Why?
|
| Animals | 2 | 1991 | 3642 | 0.020 |
Why?
|
| Exercise | 1 | 2010 | 450 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 641 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1985 | 2 | 0.020 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 4 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 4777 | 0.010 |
Why?
|
| Operon | 1 | 1990 | 1 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 1990 | 3 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1990 | 4 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1990 | 4 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1990 | 31 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1990 | 10 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1990 | 1 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1990 | 3 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1990 | 26 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 42 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1990 | 48 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1990 | 1 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1990 | 3 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1990 | 40 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1990 | 93 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1990 | 54 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1990 | 44 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 273 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 346 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 9 | 0.000 |
Why?
|
| RNA Splicing | 1 | 1987 | 10 | 0.000 |
Why?
|
| Tubulin | 1 | 1987 | 16 | 0.000 |
Why?
|
| Biological Transport | 1 | 1987 | 39 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1987 | 45 | 0.000 |
Why?
|